A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2011
11/30/2011	CN101638444B 海滨锦葵多糖制备工艺及用途 Virginica polysaccharide preparation and use
11/30/2011	CN101632663B 神经毒性的分子靶 Molecular targets neurotoxicity
11/30/2011	CN101623469B 一种古威活络酊的检测方法 An ancient method of detecting active Viagra tincture
11/30/2011	CN101564378B 左卡尼汀口服溶液及其制备方法 L-carnitine oral solution and its preparation method
11/30/2011	CN101555266B 一种替比夫定的制备方法 One kind of telbivudine preparation
11/30/2011	CN101554376B 一种高生物利用度的雷帕霉素组合物及制备方法 A highly bioavailability rapamycin compositions and methods for preparing
11/30/2011	CN101550124B 香叶木素化合物、它们的制备方法和包含它们的药物组合物 Diosmetin compounds, their preparation and pharmaceutical compositions containing them
11/30/2011	CN101537019B 一种治疗中耳炎的药物 A method of treating otitis media drug
11/30/2011	CN101534834B 包含维生素d或其衍生物的固体分散体和双膦酸盐的用于预防或治疗骨质疏松症的复合制剂 A solid dispersion containing vitamin or a derivative thereof and d bisphosphonate for prevention or treatment of osteoporosis complex formulation
11/30/2011	CN101528739B N-(2-羟基乙基)-n-甲基-4-(喹啉-8-基(1-(噻唑-4-基甲基)哌啶-4-亚基)甲基)苯甲酰胺及其制备方法和其用于治疗疼痛、焦虑症和抑郁症的用途 N- (2- hydroxyethyl) -n--methyl-4- (quinolin-8-yl (1- (thiazol-4-ylmethyl) piperidin-4-ylidene) methyl) benzamide its preparation method and its use for the treatment of pain, anxiety and depression
11/30/2011	CN101524333B 阿莫西林分散片及其生产方法 Amoxicillin tablet and its production method
11/30/2011	CN101516893B 5,7-二取代的[1,3]噻唑并[4,5-d]嘧啶-2(3h)-酮衍生物和它们在治疗中的用途 5,7-disubstituted [1,3] thiazolo [4,5-d] pyrimidin -2 (3h) - one derivatives and their use in therapy
11/30/2011	CN101511787B 作为p2x7-受体拮抗剂的被取代的n-苯基甲基-5-氧代-脯氨酸-2-酰胺及它们的使用方法 Receptor antagonists as p2x7- n- substituted phenyl-5-oxo - proline-2-carboxamide, and their use
11/30/2011	CN101502649B 一种脂质体流感疫苗 Liposome influenza vaccine
11/30/2011	CN101479273B 作为hm74a激动剂的嘌呤酮衍生物 As hm74a agonists purine derivatives
11/30/2011	CN101474256B 一种苍耳子鼻炎软胶囊制剂及其制备方法 One kind of Xanthium rhinitis soft capsule and its preparation method
11/30/2011	CN101474255B 苍耳子鼻炎胶囊的检测方法 Detection Xanthium rhinitis capsule
11/30/2011	CN101466669B 苯基吡咯氨基胍衍生物 Phenylpyrrole aminoguanidine derivatives
11/30/2011	CN101461815B 三氟柳药物组合物及其制备方法 Triflusal pharmaceutical compositions and methods for preparing
11/30/2011	CN101439187B 胆汁酸-抗肝炎病毒药物偶合物及其制药用途 Bile acid - anti-hepatitis C virus drug conjugate and pharmaceutical use
11/30/2011	CN101422534B 放疗增敏复合制剂 Radiosensitization complex preparation
11/30/2011	CN101407457B 含羧基取代的查耳酮类衍生物及制备方法和用途 Containing carboxy-substituted chalcone derivatives and preparation and use
11/30/2011	CN101367799B 苦参碱丹参酚酸b复盐和苦参素丹参酚酸b复盐及其制备方法和用途 Salvia acid b matrine and oxymatrine complex salt salvianolic acid b complex salt and its preparation method and use
11/30/2011	CN101367775B 一种绕丹宁衍生物、其制备方法及其应用 One kind of rhodanine derivatives, their preparation and their use
11/30/2011	CN101365701B 吡咯并三嗪激酶抑制剂 Pyrrolotriazine kinase inhibitors
11/30/2011	CN101365459B 磺基烷基醚环糊精组合物和其制备方法 Sulfoalkyl ether cyclodextrin compositions and methods for their preparation
11/30/2011	CN101346383B 三唑衍生物 Triazole derivatives
11/30/2011	CN101336244B 用作蛋白激酶抑制剂的9元杂二环化合物 Used as a protein kinase inhibitor compound 9 yuan heterobicycle
11/30/2011	CN101331147B 用于制备4-脱甲基柔红霉素的方法 Methods demethylation daunorubicin for the preparation of 4-
11/30/2011	CN101306011B 一种用于综合降血压的功能食品 A comprehensive hypotensive functional foods
11/30/2011	CN101289424B 一类具有高抗球虫活性和促进生长双重功效的喹酯类化合物 A class of quinoline esters with high anticoccidial activity and promote the growth of double effect
11/30/2011	CN101284855B 山茶苷a和山茶苷b的制备方法及用途 Camellianin a and b camellianin preparation and use
11/30/2011	CN101284780B 5-位酰化莽草酸及其制备和应用 5-position acylated shikimic acid and its preparation and application
11/30/2011	CN101273983B 异补骨脂甲素诱导小鼠干细胞定向分化为神经细胞的用途 Isopsoralen A-induced murine stem cells differentiate into nerve cells use
11/30/2011	CN101269057B 琥珀酸作为抗精神疾病药物增效剂的用途 Succinic acid as an anti-drug synergist use mental illness
11/30/2011	CN101209273B 旋覆花总多糖的制备及其制药用途 Preparation and pharmaceutical use of polysaccharides Inula
11/30/2011	CN101194906B 一种用于治疗过敏性疾病的滴丸及其制备方法 Dropping Pills and its preparation method for the treatment of allergic diseases
11/30/2011	CN101163486B 阿奇霉素在生产用于治疗眼部感染的药物中的用途 Azithromycin use in the manufacture of a medicament for the treatment of eye infections in
11/30/2011	CN101138569B 提高吲哚-3-甲醇及其衍生物疗效的药物组合物 Improve indol-3-methanol and its derivatives pharmaceutical composition efficacy
11/30/2011	CN101085058B 一种含有赤芍和麝香的药物组合物、制备方法和制剂 A pharmaceutical composition containing a red peony and musk, preparation methods and formulations
11/30/2011	CN101085026B 一种含有丹参和麝香的药物组合物、制备方法和制剂 The pharmaceutical compositions containing salvia and musk, preparation methods and formulations
11/30/2011	CN101085001B 一种含丹参素的复方丹参冻干粉针剂及其制备方法 Danshensu compound containing freeze-dried powder of salvia and its preparation method
11/30/2011	CN101076527B 三环酰苯胺螺乙内酰脲cgrp受体拮抗剂 Tricyclic acid anilide Lo Ethylurea cgrp receptor antagonist
11/30/2011	CN101066335B 一种治疗血栓闭塞性脉管炎、静脉炎中成药及其制作方法 An Buerger, phlebitis medicine and its production method of treatment
11/30/2011	CN101056634B 奎宁环衍生物及它们作为毒蕈碱m3受体拮抗剂的用途 Quinuclidine derivatives and their use as muscarinic m3 receptor antagonists
11/30/2011	CN101032278B 含共轭亚油酸钙的组合物及其制法 Jiqizhifa compositions containing conjugated linoleic acid calcium
11/29/2011	US8067674 Desaturase genes, enzymes encoded thereby, and uses thereof
11/29/2011	US8067639 Crystalline form VI of agomelatine, a process for its preparation and pharmaceutical compositions containing it
11/29/2011	US8067636 Dihydrazide compounds, preparation and uses thereof
11/29/2011	US8067628 Water-soluble binuclear nitrosyl iron complexes with natural aliphatic thiolyls possessing cytotoxic, apoptotic and no-donor activity
11/29/2011	US8067627 Zinc-monocysteine complex and method of using zinc-cysteine complexes
11/29/2011	US8067621 Benzenesulfonyl-chromane, thiochromane, tetrahydronaphthalene and related gamma secretase inhibitors
11/29/2011	US8067620 Dispiro 1,2,4-trioxolane antimalarials
11/29/2011	US8067615 Sulphonylpyrroles
11/29/2011	US8067614 N-substituted (benzoimidazol-2-yl)phenylamines, processes for their preparation, their use as a medicament or diagnostic aid, and a medicament comprising them
11/29/2011	US8067613 Benzimidazole poly(ADP ribose)polymerase inhibitors
11/29/2011	US8067611 Substituted 1-(thiazolyl)-and 1-(isothiazolyl)pyrazol-4-ylacetic acids, processes for their preparation and their use as herbicides and plant growth regulators
11/29/2011	US8067608 Hedgehog pathway antagonists
11/29/2011	US8067606 Gyrase inhibitors and uses thereof
11/29/2011	US8067603 Benzimidazolone and quinazolinone derivatives as agonists on human ORL1 receptors
11/29/2011	US8067600 Histone deacetylase inhibitors and methods of use thereof
11/29/2011	US8067599 Imidazo [4,5-B] pyridine and pyrrolo [2,3-B] pyridine protein kinase inhibitors
11/29/2011	US8067598 N-methyl-2-phenyl-2-{7-[2-(4-trifluoromethyl-phenyl)-ethyl]-4,7-dihydro-5H-thieno[2,3-c]pyridin-6-yl}-acetamide; sleep disorders
11/29/2011	US8067590 Melanin-concentrating hormone (MCH) receptor antagonists; treating obesity, eating disorders, affective disorders, drug dependency; compounds are amino-functional pyridazin-3-one, 1H-pyridin-2-one or 3H-pyrimidin-4-one
11/29/2011	US8067589 Heterocyclic compounds useful in treating diseases and conditions
11/29/2011	US8067586 Fused heteroaryl derivatives
11/29/2011	US8067584 Benzothiazepine derivatives
11/29/2011	US8067582 Fused heterocyclic compounds useful as modulators of nuclear hormone receptor function
11/29/2011	US8067577 Methods and compositions for the treatment of intestinal conditions
11/29/2011	US8067576 siRNA targeting serine/threonine kinase 12 (STK12 or aurora B kinase)
11/29/2011	US8067575 RNA interference mediated inhibition of cyclin D1 gene expression using short interfering nucleic acid (siNA)
11/29/2011	US8067571 Conjugating an arginine-rich carrier to a 3' or 5' end; phosphorodiamidate linkages
11/29/2011	US8067570 Therapeutic uses of inhibitors of RTP801
11/29/2011	US8067569 Splice-region antisense composition and method
11/29/2011	US8067505 Method of preparing carboxylic acid functionalized polymers
11/29/2011	US8067473 Methods for enhancing the therapeutic efficacy of topoisomerase inhibitors
11/29/2011	US8067472 Methods of treating Hodgkin's and non-Hodgkin's lymphoma
11/29/2011	US8067471 Composition comprising free amino acids
11/29/2011	US8067470 Linoleic acid preparations for the topical treatment of male and female pattern androgenetic alopecia, age-related alopecia, and keratosis pilaris
11/29/2011	US8067468 L-carnitine and alkanoyl L-carnitine phytates and process for preparing the same
11/29/2011	US8067467 Thiosuccinic acid derivatives and the use thereof
11/29/2011	US8067466 Cycloalkyl-hydroxyl compounds and compositions for cholesterol management
11/29/2011	US8067465 Tricyclic-bis-enone derivatives and methods of use thereof
11/29/2011	US8067464 Compositions and methods using apocynin compounds and nitric oxide donors
11/29/2011	US8067463 Protease inhibitor precursor synthesis
11/29/2011	US8067462 Processes of making sesquiterpenoid tashironin, its analogs and their uses
11/29/2011	US8067461 3-acyl coumarins, thiochromones and quinolones and therapeutic uses thereof
11/29/2011	US8067460 5-phenoxyalkoxypsoralens and methods for selective inhibition of the voltage gated Kv1.3 potassium channel
11/29/2011	US8067459 Lapachone compounds and methods of use thereof
11/29/2011	US8067458 Alkoxyalkyl-substituted cyclic ketoenols
11/29/2011	US8067457 Compounds useful as antagonists of CCR2
11/29/2011	US8067456 Tetrahydrocarbazole derivatives having improved biological action and improved solubility as ligands of G-protein coupled receptors (GPCPs)
11/29/2011	US8067455 Amino acid derived prodrugs of propofol, compositions, uses and crystalline forms thereof
11/29/2011	US8067453 Oxazole compound to treat or prevent diabetic neuropathy; 4-(4-chlorophenyl)-5-(3-(2-methoxyphenoxy)propyl-2-methyl-1-imidazolyl)oxazole
11/29/2011	US8067452 3-hydroxyisothiazole-4-carboxamidine derivatives as CHK2 inhibitors
11/29/2011	US8067451 Oral dosage form comprising therapeutically effective dosage of ibuprofen and famotidine is administered three times per day; side effect reduction; antiulcer agents
11/29/2011	US8067450 Thiazolidinedione analogues for the treatment of metabolic diseases
11/29/2011	US8067449 Modulators of pharmacokinetic properties of therapeutics
11/29/2011	US8067448 Selective androgen receptor modulators
11/29/2011	US8067447 Modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof

1 ... 1463 1464 1465 1466 1467 1468 1469 1470 1471 1472 1473 1474 1475 1476 1477 1478 1479 1480 1481 1482 1483 ... 7860